Nyxoah SA

NYXH Healthcare Medical Instruments & Supplies

Nyxoah SA’s revenue for fiscal 2025 (year ended December 2025) was $11.3 million, up 131.7% from fiscal 2024. In the quarter to June 2026, revenue grew 486.6%, EPS fell 6.35%, free cash flow grew 4.01% and total debt rose 185.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

1.11 0.08 −6.72%
Market cap
$121.2M
P/E
0.0×
Fwd P/E
−1.7×
Dividend yield
—
F-score
3/9
Altman Z
−4.39
Beneish M
−2.78
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Total current assets
69.26 106.14 73.98 105.63 165.71 107.50 8.96 20.16 12.87
Total non-current assets
64.78 65.28 60.40 48.27 36.40 22.81 — — —
Total Assets
134.04 171.41 134.38 153.90 202.11 130.31 17.07 20.67 —
Total current liabilities
55.39 23.30 15.63 15.71 13.69 7.31 4.92 2.30 2.11
Total non-current liabilities
23.06 25.56 12.65 11.41 12.58 11.98 — — —
Total liabilities
78.45 48.86 28.29 27.13 26.27 19.29 14.42 8.65 7.97
Common Equity (Total)
55.58 122.55 106.09 126.77 175.83 111.02 2.65 12.02 5.45
Shareholders Equity (Total)
55.58 122.55 106.09 126.77 175.83 111.02 2.65 12.02 5.45
Total Debt
46.72 23.30 12.83 11.76 13.12 12.64 9.66 6.68 6.34

Show all line items

In millions of $ except per-share values · columns are period end dates